Global Med Technologies(R), Inc. Signs Five-Year $1.2 Million Contract With Prestigious City of Hope National Medical Center
December 09 2003 - 10:00AM
PR Newswire (US)
Global Med Technologies(R), Inc. Signs Five-Year $1.2 Million
Contract With Prestigious City of Hope National Medical Center City
of Hope Selects SafeTrace(R) and SafeTrace Tx(R) DENVER, Dec. 9
/PRNewswire-FirstCall/ -- Wyndgate Technologies(R), a division of
Global Med Technologies(R), Inc. (BULLETIN BOARD: GLOB) ("Global
Med" or the "Company"), announced the signing of an agreement for
its Vein-to-Vein(R) software, SafeTrace(R) donor management and
SafeTrace Tx(R)* advanced transfusion management, with City of Hope
National Medical Center. With a potential value of $1.2 million
over a five-year period, City of Hope will be the largest user of
Wyndgate's Vein-to-Vein software in California. Thomas F. Marcinek,
President and COO of Global Med Technologies, Inc., stated, "We are
pleased to announce this significant business agreement with City
of Hope, a very prestigious organization, which is leading the way
in cancer research and providing treatments to so many patients
with life-threatening illnesses." Mr. Marcinek added, "Our
five-year agreement underscores Wyndgate's commitment to safety and
quality in helping facilities, such as City of Hope, manage and
track blood products from collection to transfusion, using our
Vein-to-Vein software. Wyndgate looks forward to a successful
partnership with City of Hope." About City of Hope City of Hope
National Medical Center is located northeast of Los Angeles in
Duarte, California. City of Hope is one of a few prominent
Comprehensive Cancer Centers in the United States as designated by
the National Cancer Institute (NCI). More than 300 physicians and
scientists and over 2,500 employees work at City of Hope to find
the causes of and cures for cancer and other life-threatening
diseases, including diabetes and HIV/AIDS. For more information
about City of Hope, visit its website at
http://www.cityofhope.org/. About Global Med Technologies, Inc.
Global Med Technologies, Inc. is an e-Health, medical information
technology company, providing information management software
products and services to the healthcare industry. Its Wyndgate
Technologies division is a leading supplier of information
management systems to U.S. blood centers and transfusion services.
Current clients of Wyndgate's products and services manage more
than 3 million units of blood, or over 22% of the U.S. blood
supply, each year. Together, SafeTrace Tx and SafeTrace provide
Vein-to-Vein tracking from donor collection to patient transfusion.
For more information about Global Med's products and services, call
800-WYNDGATE or visit http://www.globalmedtech.com/,
http://www.peoplemed.com/ and http://www.wyndgate.com/. This news
release may include statements that constitute forward-looking
statements, usually containing the words "believe," "estimate,"
"project," "expects" or similar expressions. These statements are
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements inherently involve risks and uncertainties that could
cause actual results to differ materially from the forward-looking
statements. By making these forward-looking statements, the Company
undertakes no obligation to update these statements for revisions
or changes after the date of this news release. * Patent Pending
DATASOURCE: Global Med Technologies, Inc. CONTACT: press, Patti
Larson, Senior Director of Marketing Development, +1-916-404-8492,
, or investors, Tom Marcinek, President and COO, +1-916-404-8413, ,
both of Wyndgate Technologies, for Global Med Technologies Web
site: http://www.cityofhope.org/ Web site: http://www.wyndgate.com/
Web site: http://www.peoplemed.com/ Web site:
http://www.globalmedtech.com/ x
Copyright